Cancer patterns and trends in Central and South America

Slides:



Advertisements
Similar presentations
Slides last updated: March 2015 CRC: EPIDEMIOLOGY.
Advertisements

Cancer in Ontario: Overview A Statistical Report.
Regional variation in histopathology-specific incidence of invasive cervical cancer among Peruvian women Christine M. Pierce Campbell, Maria P. Curado,
Gastric cancer Critical Reviews in Oncology / Hematology
Thyroid cancer burden in Central and South America
Thyroid cancer burden in Central and South America
Comparison of expected health impacts for major cancers: Integration of incidence rate and loss of quality-adjusted life expectancy  Mei-Chuan Hung, Wu-Wei.
Volume 38, Issue 6, Pages (December 2014)
Marion Piñeros, Mónica S. Sierra, M. Isabel Izarzugaza, David Forman 
Volume 44, Pages S43-S52 (September 2016)
Stomach cancer burden in Central and South America
Prostate cancer burden in Central and South America
Volume 68, Pages S46-S52 (August 2005)
Volume 39, Issue 1, Pages (February 2015)
Volume 46, Pages 1-8 (February 2017)
Chronic Pain Management in Older Adults: Special Considerations
S.E. Knapen, M. van de Werken, M.C.M. Gordijn, Y. Meesters 
Melanoma in adolescents and young adults (ages years): United States,  
Global Trends in Testicular Cancer Incidence and Mortality
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
Epidemiology and Risk Factors of Urothelial Bladder Cancer
INCIDENCE.
Prostate Cancer Epidemic in Sight?
Chronic Pain Management in Older Adults: Special Considerations
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Volume 68, Issue 5, Pages (November 2015)
Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population  D. Nowakowska,
Melanoma in adolescents and young adults (ages years): United States,  
Gastric cancer, cytotoxin-associated gene A–positive Helicobacter pylori, and serum pepsinogens: An international study  Penelope M. Webb, Jean E. Crabtree,
Danny R. Youlden, BSc, Susanna M. Cramb, MPH, Peter D. Baade, PhD 
Prostate Cancer Epidemic in Sight?
Epidemiology of Myelodysplastic Syndromes
Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany
Volume 58, Issue 3, Pages (September 2010)
Ting-Yuan David Cheng, PhD, Susanna M. Cramb, PhD, Peter D
Volume 58, Issue 3, Pages (March 2013)
Volume 18, Issue 12, Pages (December 2017)
Aaron P. Thrift, PhD  Clinical Gastroenterology and Hepatology 
Elina Jerschow, MD, MSc, Robert Y. Lin, MD, MSc, Moira M
National Cancer Statistics in Korea, 2015
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Ten years incidence of cancer in Iran; a systematic review and meta-analysis  Samira Beiranvand, Kourosh Zarea, Saeed Ghanbari, Hanna Tuvesson, Bijan Keikhaei 
Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults  Mark P. Purdue, Laura E. Beane Freeman, William F. Anderson, Margaret.
Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region  K.B. Laupland, M.D. Parkins, T. Ross, J.D.D. Pitout 
Confessions of a journal junkie
Kamila Czene, Ph.D., Kari Hemminki  Kidney International 
Volume 130, Issue 6, (September 2007)
Apparent decreases in Swedish public health indicators after 1997—Are they due to improved diagnostics or to environmental factors?  Örjan Hallberg, Olle.
Jianguang Ji, Kari Hemminki  Clinical Gastroenterology and Hepatology 
Hashem El–Serag, Anna S.F. Lok, David L. Thomas  Gastroenterology 
Vincent L. Rowe, MD, William Lee, MD, Fred A
Volume 68, Pages S46-S52 (August 2005)
Community-acquired pneumonia: epidemiologic and clinical consideration
CPR 1.2.: Evaluation of Anemia in CKD
Low-technology approaches
Volume 16, Issue 1, Pages (January 2015)
Cynthia Holterhues, Esther de Vries, Marieke W
Skin cancer epidemic in a wireless world
Alexander Liede, Imtiaz A
The failure of breast cancer screening
Observations on emerging patterns of asthma in our society
Volume 138, Issue 6, Pages (May 2010)
Epidemiology and Demographics of Prostatitis
IASLC 6th Latin American Conference on Lung Cancer
Quality of life: An outcomes perspective
Absence of a gender gap in survival
Epidemiology of Thymoma and Associated Malignancies
Volume 134, Issue 6, (September 2008)
(A) Trends in colorectal cancer incidence and mortality in males (M) and females (F) by country (group 1: increasing or stable incidence and mortality).
Volume 374, Issue 9694, Pages (September 2009)
Presentation transcript:

Cancer patterns and trends in Central and South America Mónica S. Sierra, Isabelle Soerjomataram, Sébastien Antoni, Mathieu Laversanne, Marion Piñeros, Esther de Vries, David Forman  Cancer Epidemiology  Volume 44, Pages S23-S42 (September 2016) DOI: 10.1016/j.canep.2016.07.013 Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 1 Cancers ranked* by age-standardized incidence rates among males in Central and South America. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 2 Cancers ranked* by age-standardized mortality rates among males in Central and South America. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 3 Cancers ranked* by age-standardized incidence rates among females in Central and South America. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 4 Cancers ranked* by age-standardized mortality rates among females in Central and South America. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 5 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 5 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. 5 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. A1 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. A1 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. A1 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. A1 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions

Fig. A1 Age-standardized incidence (light) and mortality (dark) rates per 100,000 for selected cancers in Central and South America for the period 2003–2007, unless otherwise specified†. †Period of national mortality data matched as close as possible to the incidence period. 1Incidence rates were estimated using aggregated data from regional cancer registries. Cancer Epidemiology 2016 44, S23-S42DOI: (10.1016/j.canep.2016.07.013) Copyright © 2016 International Agency for Research on Cancer Terms and Conditions